Regarding ARHGAP33, researchers have reported that it is a marker gene that can predict prognosis in prostate cancer [15], and ARHGAP family genes have been demonstrated to promote bladder cancer progression by establishing a tumor-promoting microenvironment [16]. This evidence concerns the gene ARHGAP33 and neoplasm.